Mauro Sousa de Almeida

Mr. Mauro Sousa de Almeida

Adolphe Merkle Institute
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Chemical Society Reviews
Verified
Journal Article
Open access
PDF file
MAMauro Sousa de Almeida
Mauro Sousa de Almeida
Eva SusnikEva Susnik
Eva Susnik
BDBarbara Drasler
Barbara Drasler
PTPatricia Taladriz
Patricia Taladriz
Alke FinkAlke Fink
Alke Fink
BRBarbara Rothen-Rutishauser
Barbara Rothen-Rutishauser
This review contributes to the current understanding of NPs cellular uptake and gives an overview about molecules, which can enhance or decrease cellular internalization of NPs.

30 December 2017 in Journal of Polymer Research
Verified
Journal Article
Closed access
PDF file
MAMauro Sousa de Almeida
Mauro Sousa de Almeida
MMMariana Magalhães
Mariana Magalhães
Francisco VeigaFrancisco Veiga
Francisco Veiga
AFAna Figueiras
Ana Figueiras

3 October 2022 in Nanoscale
Verified
Journal Article
Open access
PDF file
ALAaron Lee
Aaron Lee
MAMauro Sousa de Almeida
Mauro Sousa de Almeida
DMDaela Milinkovic
Daela Milinkovic
DSDedy Septiadi
Dedy Septiadi
PTPatricia Taladriz
Patricia Taladriz
Alke FinkAlke Fink
Alke Fink
Cells continuously exert forces on their environment and respond to changes in mechanical forces by altering their behaviour. Many pathologies such as cancer and fibrosis are hallmarked by dysregulation in the extracellular matrix, driving aberrant behaviour through mechanotransduction pathways. We demonstrate that substrate stiffness can be used to regulate cellular endocytosis of particles in a size-dependent fashion. Culture of A549 epithelial cells and J774A.1 macrophages on polystyrene/glass (stiff) and polydimethylsiloxane (soft) substrates indicated that particle uptake is increased up to six times for A549 and two times for macrophages when cells are grown in softer environments. Furthermore, we altered surface characteristics through the attachment of submicron-sized particles as a method to locally engineer substrate stiffness and topography to investigate the biomechanical changes which occurred within adherent epithelial cells, i.e. characterization of A549 cell spreading and focal adhesion maturation. Consequently, decreasing substrate rigidity and particle-based topography led to a reduction of focal adhesion size. Moreover, expression levels of Yes-associated protein were found to correlate with the degree of particle endocytosis. A thorough appreciation of the mechanical cues may lead to improved solutions to optimize nanomedicine approaches for treatment of cancer and other diseases with abnormal mechanosignalling.

1 October 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MMMariana Magalhães
Mariana Magalhães
MAMauro Sousa de Almeida
Mauro Sousa de Almeida
ESElisiário Tavares da Silva
Elisiário Tavares da Silva
FRFernanda M.F. Roleira
Fernanda M.F. Roleira
CVCarla Varela
Carla Varela
AFAna Figueiras
Ana Figueiras

21 August 2020 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
BDBarbara Drasler
Barbara Drasler
BKBedia Begum Karakocak
Bedia Begum Karakocak
ETEsma Bahar Tankus
Esma Bahar Tankus
HBHana Barosova
Hana Barosova
JAJun Abe
Jun Abe
BRBarbara Rothen-Rutishauser
Barbara Rothen-Rutishauser
A large number of prevalent lung diseases is associated with tissue inflammation. Clinically, corticosteroid therapies are applied systemically or via inhalation for the treatment of lung inflammation, and a number of novel therapies are being developed that require preclinical testing. In alveoli, macrophages and dendritic cells play a key role in initiating and diminishing pro-inflammatory reactions and, in particular, macrophage plasticity (M1 and M2 phenotypes shifts) has been reported to play a significant role in these reactions. Thus far, no studies with in vitro lung epithelial models have tested the comparison between systemic and direct pulmonary drug delivery. Therefore, the aim of this study was to develop an inflamed human alveolar epithelium model and to test the resolution of LPS-induced inflammation in vitro with a corticosteroid, methylprednisolone (MP). A specific focus of the study was the macrophage phenotype shifts in response to these stimuli. First, human monocyte-derived macrophages were examined for phenotype shifts upon exposure to lipopolysaccharide (LPS), followed by treatment with MP. A multicellular human alveolar model, composed of macrophages, dendritic cells, and epithelial cells, was then employed for the development of inflamed models. The models were used to test the anti-inflammatory potency of MP by monitoring the secretion of pro-inflammatory mediators (interleukin [IL]-8, tumor necrosis factor-α [TNF-α], and IL-1β) through four different approaches, mimicking clinical scenarios of inflammation and treatment. In macrophage monocultures, LPS stimulation shifted the phenotype towards M1, as demonstrated by increased release of IL-8 and TNF-α and altered expression of phenotype-associated surface markers (CD86, CD206). MP treatment of inflamed macrophages reversed the phenotype towards M2. In multicellular models, increased pro-inflammatory reactions after LPS exposure were observed, as demonstrated by protein secretion and gene expression measurements. In all scenarios, among the tested mediators the most pronounced anti-inflammatory effect of MP was observed for IL-8. Our findings demonstrate that our inflamed multicellular human lung model is a promising tool for the evaluation of anti-inflammatory potency of drug candidates in vitro. With the presented setup, our model allows a meaningful comparison of the systemic vs. inhalation administration routes for the evaluation of the efficacy of a drug in vitro.

18 February 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MAMauro Sousa de Almeida
Mauro Sousa de Almeida
PTPatricia Taladriz
Patricia Taladriz
BDBarbara Drasler
Barbara Drasler
BSBalog Sandor
Balog Sandor
PYPhattadon Yajan
Phattadon Yajan
BRBarbara Rothen-Rutishauser
Barbara Rothen-Rutishauser
The approval of new nanomedicines requires a deeper understanding of the interaction between cells and nanoparticles (NPs). Silica (SiO2) and gold (Au) NPs have shown great potential in biomedical applications, such as the delivery of therapeutic agents, diagnostics, and biosensors. NP-cell interaction and internalization can trigger several cellular responses, including gene expression regulation. The identification of differentially expressed genes in response to NP uptake contributes to a better understanding of the cellular processes involved, including potential side effects. We investigated gene regulation in human macrophages and lung epithelial cells after acute exposure to spherical 60 nm SiO2 NPs. SiO2 NPs uptake did not considerably affect gene expression in epithelial cells, whereas five genes were up-regulated in macrophages. These genes are principally related to inflammation, chemotaxis, and cell adhesion. Nuclear receptor NR4A1, an important modulator of inflammation in macrophages, was found to be up-regulated. The expression of this gene was also increased upon 1 h of macrophage exposure to spherical 50 nm AuNPs and 200 nm spherical SiO2 NPs. NR4A1 can thus be an important immediate regulator of inflammation provoked by NP uptake in macrophages.